Alcohol metabolism in liver sinusoidal endothelial cells
Alcohol metabolism in liver sinusoidal endothelial cells
批准号:
8965570
负责人:
YASUKO IWAKIRI
金额:
$23.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2017-07-31
关键词:
AcetaldehydeAcetylationAlcohol abuseAlcohol consumptionAlcoholic Fatty LiverAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholsApoptosisBloodBlood VesselsCYP2E1 geneCell physiologyCellsChemicalsCirrhosisComplexCytochrome P-450 CYP2E1DataDevelopmentDietEarly InterventionEndothelial CellsEnzymesEthanolEthanol MetabolismFibrosisFunctional disorderGenesGoalsHeat-Shock Proteins 90HepatocyteIn VitroInjuryKnock-outKnockout MiceKupffer CellsLeadLiverLiver DysfunctionLiver diseasesMaintenanceMeasuresMediatingMetabolicMolecularMovementMusNitric OxideNitric Oxide SynthaseOxidative StressPharmaceutical PreparationsPrimary carcinoma of the liver cellsProductionProteinsReactive Oxygen SpeciesRegulationResearchRoleStructureTestingTissuesalcohol responsechronic alcohol ingestiondrug metabolismeffective therapyfeedinghuman NOS3 proteinin vivointrahepaticpreventprotein protein interactionpublic health relevanceresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Liver sinusoidal endothelial cells (LSECs) protect the liver, acting as the first barrier against insults coming from the sinusoidal blood. LSEC dysfunction is associated with the development of a wide range of liver diseases including alcohol liver disease. Cytochrome P450 2E1 (CYP2E1) is a key enzyme in alcohol and drug metabolism. Induction of CYP2E1 by alcohol generates metabolic products, such as reactive oxygen species (ROS), which cause tissue injury. The study of CYP2E1 in the liver has largely focused on hepatocytes. The presence and function of CYP2E1 in LSECs remains unknown. We recently found that CYP2E1 is expressed in LSECs. This finding is important, since it implies that LSEC-mediated metabolism of alcohol may generate metabolites that impair normal endothelial cell function. The goal of this study is to understand the role of CYP2E1 in LSECs in ethanol-induced liver injury. Dysfunctional LSECs are characterized by loss of fenestrae and decreased nitric oxide (NO) production. NO is a key regulator of intrahepatic vascular tone. NO is also essential for the maintenance of LSEC's fenestrae structure, which allows bi-directional movement of proteins and other substances between blood vessels and hepatocytes. Chronic alcohol consumption decreases endothelial NO synthase (eNOS)-derived NO production. Further, blocking NO production enhances ethanol-induced liver injury, suggesting NO's protective role. The mechanisms by which alcohol consumption diminishes eNOS activity and NO production are unknown. We hypothesize that ethanol induces CYP2E1 expression in LSECs and that induced CYP2E1 in turn decreases eNOS-derived NO production. To test these hypotheses, we will propose the following two aims: 1) Define the role of CYP2E1 in LSEC function in response to ethanol, and 2) Define CYP2E1-dependent regulation of NO production in LSECs in response to ethanol. Given that CYP2E1 metabolizes a wide range of drugs and chemicals besides alcohol, this study will also open the door to reveal LSEC's role in metabolizing those substances, which has most commonly been attributed to hepatocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hepatic lymphatics in alcohol-associated liver disease
-
批准号:10824029
-
项目类别:
-
资助金额:$21.16万
-
财政年份:2023
-
负责人:YASUKO IWAKIRI
-
依托单位:
Lymphatics in the liver
-
批准号:10391056
-
项目类别:
-
资助金额:$62.17万
-
财政年份:2022
-
负责人:YASUKO IWAKIRI
-
依托单位:
Lymphatics in the liver
-
批准号:10657334
-
项目类别:
-
资助金额:$58.93万
-
财政年份:2022
-
负责人:YASUKO IWAKIRI
-
依托单位:
Endotheliopathy and liver injury in COVID-19
-
批准号:10468220
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:YASUKO IWAKIRI
-
依托单位:
Endotheliopathy and liver injury in COVID-19
-
批准号:10662455
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:YASUKO IWAKIRI
-
依托单位:
Endotheliopathy and liver injury in COVID-19
-
批准号:10319358
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:YASUKO IWAKIRI
-
依托单位:
Hemodynamics and hepatic remodeling
-
批准号:9920142
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2018
-
负责人:YASUKO IWAKIRI
-
依托单位:
Hemodynamics and hepatic remodeling
-
批准号:9542958
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2018
-
负责人:YASUKO IWAKIRI
-
依托单位:
The role of Kupffer cells in alcohol-induced liver disease
-
批准号:9761401
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2017
-
负责人:YASUKO IWAKIRI
-
依托单位:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
-
批准号:8969937
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2016
-
负责人:YASUKO IWAKIRI
-
依托单位:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
-
批准号:9326892
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2016
-
负责人:YASUKO IWAKIRI
-
依托单位:
Alcohol metabolism in liver sinusoidal endothelial cells
-
批准号:9116749
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2015
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8500246
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8286394
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:7729752
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8587675
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8085781
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8724090
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8913298
-
项目类别:
-
资助金额:$6.1万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:7848984
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
海外基金